Why vaccinate children against COVID?

Advertisement

Pharmaceutical giant Pfizer is now testing a third vaccine dose in children under five, claiming two doses are not strong enough:

Pfizer announced the change after preliminary analysis found the immune response to the very low-dose shots, the company is testing in the children, was not as strong as expected.

The news is disappointing for families anxious to vaccinate their kids…

The full text of this article is available to MacroBusiness subscribers

$1 for your first month, then:
Cancel at any time through our billing provider, Stripe
About the author
Leith van Onselen is Chief Economist at the MB Fund and MB Super. He is also a co-founder of MacroBusiness. Leith has previously worked at the Australian Treasury, Victorian Treasury and Goldman Sachs.